Guest guest Posted August 26, 2011 Report Share Posted August 26, 2011 FDA approves HCV treatment for children The FDA has approved an expansion of the indication for the combination of peginterferon alfa-2a (40 KD) and ribavirin to be used in patients with chronic hepatitis C aged 5 to 17 years. The indication is for patients with compensated liver disease and no prior history of interferon therapy. Read more Resource Center: Hepatitis C Visit the Infectious Disease News Hepatitis C Resource Center, where you'll find the latest information on the diagnosis, management and treatment of HCV, as well as up-to-date information on risk factors contributing to the condition.http://www.infectiousdiseasenews.com/Hepatitis C/ Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 26, 2011 Report Share Posted August 26, 2011 FDA approves HCV treatment for children The FDA has approved an expansion of the indication for the combination of peginterferon alfa-2a (40 KD) and ribavirin to be used in patients with chronic hepatitis C aged 5 to 17 years. The indication is for patients with compensated liver disease and no prior history of interferon therapy. Read more Resource Center: Hepatitis C Visit the Infectious Disease News Hepatitis C Resource Center, where you'll find the latest information on the diagnosis, management and treatment of HCV, as well as up-to-date information on risk factors contributing to the condition.http://www.infectiousdiseasenews.com/Hepatitis C/ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.